Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25948862.
- Also identified by DOI 10.1093/infdis/jiv203 and PMC identifier 4564546.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most ebolaviruses can cause severe disease in humans and other primates, with high case fatality rates during human outbreaks. Although these viruses have been studied for almost 4 decades, little is know regarding the mechanisms by which they cause disease and what is important for protection or treatment after infection. Because of the sporadic nature of the outbreaks and difficulties accessing the populations affected by ebolaviruses, little is also known about what constitutes an appropriate immune response to infection in humans that survive infection. Such knowledge would allow a targeted approach to therapies. In contrast to humans, rodents are protected from disease on infection with ebolaviruses, although adapted versions of some of the viruses are lethal in mice, hamsters and guinea pigs. Using the recently described hamster model, along with T-cell depletion strategies, we show that CD4(+) T cells are required for natural immunity to Ebola virus infection and that CD4-dependent antibody responses are required for immunity in this model.
Medical subject headings
- Antibodies, Viral
- Antibody Formation
- Ebolavirus
- Hemorrhagic Fever, Ebola
- Immunity, Innate
- Mesocricetus